| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |